CLINICAL_TRIALS
trial_result
· 2021-03-23
Clinical Trial Update: Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of tanezumab in patients with chronic pancreatitis; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Chronic Pancreatitis | Phase 2 | Status: TERMINATED | Results posted: 2021-03-23